history of glp 1 drugs agonists Discovery GLP-1–Based for the Treatment of Obesity GLP-1 Agonists: A Comprehensive Overview – What are GLP-1s? | Mendinground

The prescription peptides semaglutide, liraglutide, and tirzepatide are generally intended for people with a body mass index (BMI) of 30 or higher , or a BMI of 27 or higher with weight-related health conditions such as type 2 diabetes, high blood pressure, or sleep apnea (FDA Wegovy prescribing information)

Very few weight-loss approaches come close

For those interested in B12 for mood and focus, studies suggest a connection between vitamin B12 and neurotransmitters involved in emotional balance and concentration

Mechanisms of NO neurotoxicity

In the United States, Ipamorelin and CJC-1295 are not approved by the FDA for human consumption, meaning they are legally sold only for research purposes